FDA Inspection 831892 — Delaware Institute for Reproductive Medicine, P.A

Delaware Institute for Reproductive Medicine, P.A — FEI 3003939643

The FDA completed an inspection of Delaware Institute for Reproductive Medicine, P.A on May 16, 2013 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 16, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Newark, DE (United States)